This Article Full Text Full Text (PDF) All Versions of this Article: 47/6/1183    most recent 01.HYP.0000221429.94591.72v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hattori, Y. Articles by Kasai, K. Search for Related Content PubMed PubMed Citation Articles by Hattori, Y. Articles by Kasai, K. Related Collections Cell signalling/signal transduction Type 2 diabetes Endothelium/vascular type/nitric oxide

(Hypertension. 2006;47:1183.)
© 2006 American Heart Association, Inc.

Original Articles

Metformin Inhibits Cytokine-Induced Nuclear Factor B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells

Yoshiyuki Hattori; Kunihiro Suzuki; Sachiko Hattori; Kikuo Kasai

From the Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan.

Correspondence to Yoshiyuki Hattori, Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan. E-mail yhattori{at}dokkyomed.ac.jp

AMP-activated protein kinase (AMPK) is tightly regulated by the cellular AMP:ATP ratio and plays a central role in regulation of energy homeostasis and metabolic stress. Metformin has been shown to activate AMPK. We hypothesized that metformin may prevent nuclear factor B (NF-B) activation in endothelial cells exposed to inflammatory cytokines. Metformin was observed to activate AMPK, as well as its downstream target, phosphoacetyl coenzyme A carboxylase, in human umbilical vein endothelial cells (HUVECs). Metformin also dose-dependently inhibited tumor necrosis factor (TNF)-–induced NF-B activation and TNF-–induced IB kinase activity. Furthermore, metformin attenuated the TNF-–induced gene expression of various proinflammatory and cell adhesion molecules, such as vascular cell adhesion molecule-1, E-selectin, intercellular adhesion molecule-1, and monocyte chemoattractant protein-1, in HUVECs. A pharmacological activator of AMPK, 5-amino-4-imidazole carboxamide riboside (AICAR), dose-dependently inhibited TNF-- and interleukin-1ß–induced NF-B reporter gene expression. AICAR also suppressed the TNF-- and interleukin-1ß–induced gene expression of vascular cell adhesion molecule-1, E-selectin, intercellular adhesion molecule-1, and monocyte chemoattractant protein-1 in HUVECs. The small interfering RNA for AMPK1 attenuated metformin or AICAR–induced inhibition of NF-B activation by TNF-, suggesting a possible role of AMPK in the regulation of cell inflammation. In light of these findings, we suggest that metformin attenuates the cytokine-induced expression of proinflammatory and adhesion molecule genes by inhibiting NF-B activation via AMPK activation. Thus, it might be useful to target AMPK signaling in future efforts to prevent atherogenic and inflammatory vascular disease.

Key Words: endothelium • cell adhesion molecules • diabetes mellitus

This article has been cited by other articles:

				J. Xu and M.-H. Zou Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction Circulation, September 29, 2009; 120(13): 1266 - 1286. [Full Text] [PDF]

				N. Nath, M. Khan, M. K. Paintlia, M. N. Hoda, and S. Giri Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis J. Immunol., June 15, 2009; 182(12): 8005 - 8014. [Abstract] [Full Text] [PDF]

				Y. Wang, Y. Huang, K. S.L. Lam, Y. Li, W. T. Wong, H. Ye, C.-W. Lau, P. M. Vanhoutte, and A. Xu Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase Cardiovasc Res, June 1, 2009; 82(3): 484 - 492. [Abstract] [Full Text] [PDF]

				H. W. Jeong, K. C. Hsu, J.-W. Lee, M. Ham, J. Y. Huh, H. J. Shin, W. S. Kim, and J. B. Kim Berberine suppresses proinflammatory responses through AMPK activation in macrophages Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E955 - E964. [Abstract] [Full Text] [PDF]

				A. M. Bair, P. B. Thippegowda, M. Freichel, N. Cheng, R. D. Ye, S. M. Vogel, Y. Yu, V. Flockerzi, A. B. Malik, and C. Tiruppathi Ca2+ Entry via TRPC Channels Is Necessary for Thrombin-induced NF-{kappa}B Activation in Endothelial Cells through AMP-activated Protein Kinase and Protein Kinase C{delta} J. Biol. Chem., January 2, 2009; 284(1): 563 - 574. [Abstract] [Full Text] [PDF]

				Y. Hattori, K. Suzuki, A. Tomizawa, N. Hirama, T. Okayasu, S. Hattori, H. Satoh, K. Akimoto, and K. Kasai Cilostazol inhibits cytokine-induced nuclear factor-{kappa}B activation via AMP-activated protein kinase activation in vascular endothelial cells Cardiovasc Res, January 1, 2009; 81(1): 133 - 139. [Abstract] [Full Text] [PDF]

				B. T. Bikman, D. Zheng, W. J. Pories, W. Chapman, J. R. Pender, R. C. Bowden, M. A. Reed, R. N. Cortright, E. B. Tapscott, J. A. Houmard, et al. Mechanism for Improved Insulin Sensitivity after Gastric Bypass Surgery J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4656 - 4663. [Abstract] [Full Text] [PDF]

				V. D. Dixit Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span J. Leukoc. Biol., October 1, 2008; 84(4): 882 - 892. [Abstract] [Full Text] [PDF]

				B. Chandrasekar, W. H. Boylston, K. Venkatachalam, N. J. G. Webster, S. D. Prabhu, and A. J. Valente Adiponectin Blocks Interleukin-18-mediated Endothelial Cell Death via APPL1-dependent AMP-activated Protein Kinase (AMPK) Activation and IKK/NF-{kappa}B/PTEN Suppression J. Biol. Chem., September 5, 2008; 283(36): 24889 - 24898. [Abstract] [Full Text] [PDF]

				X. Zhao, J. W. Zmijewski, E. Lorne, G. Liu, Y.-J. Park, Y. Tsuruta, and E. Abraham Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L497 - L504. [Abstract] [Full Text] [PDF]

				H. C. Choi, P. Song, Z. Xie, Y. Wu, J. Xu, M. Zhang, Y. Dong, S. Wang, K. Lau, and M.-H. Zou Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statin in Vivo J. Biol. Chem., July 18, 2008; 283(29): 20186 - 20197. [Abstract] [Full Text] [PDF]

				J. W. Zmijewski, E. Lorne, X. Zhao, Y. Tsuruta, Y. Sha, G. Liu, G. P. Siegal, and E. Abraham Mitochondrial Respiratory Complex I Regulates Neutrophil Activation and Severity of Lung Injury Am. J. Respir. Crit. Care Med., July 15, 2008; 178(2): 168 - 179. [Abstract] [Full Text] [PDF]

				S. S Lund, L. Tarnow, C. D A Stehouwer, C. G Schalkwijk, T. Teerlink, J. Gram, K. Winther, M. Frandsen, U. M Smidt, O. Pedersen, et al. Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes Eur. J. Endocrinol., May 1, 2008; 158(5): 631 - 641. [Abstract] [Full Text] [PDF]

				S. Qin, M. Ni, and G. W. De Vries Implication of S-Adenosylhomocysteine Hydrolase in Inhibition of TNF-{alpha}- and IL-1{beta}-Induced Expression of Inflammatory Mediators by AICAR in RPE Cells Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1274 - 1281. [Abstract] [Full Text] [PDF]

				N. F Wiernsperger Review: 50 years later: is metformin a vascular drug with antidiabetic properties? The British Journal of Diabetes & Vascular Disease, September 1, 2007; 7(5): 204 - 210. [Abstract] [PDF]

				F. S. Gaskin, K. Kamada, M. Yusof, and R. J. Korthuis 5'-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H326 - H332. [Abstract] [Full Text] [PDF]